Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

3 articles from the last 90 days matching "Zika Virus Infection"

PolicyEMAMay 12

EMA actively monitoring cruise ship Hantavirus outbreak

The European Medicines Agency (EMA) is closely watching an outbreak of Andes hantavirus that started on a cruise ship. Hantavirus is a serious infection spread by infected rodents that can cause severe lung and kidney problems in people. The EMA is working with other European health organizations to monitor the situation and make sure patients get proper treatment.

WHY IT MATTERSIf you or a family member traveled on the affected cruise ship or have symptoms like fever, muscle aches, and difficulty breathing, this outbreak alert helps you understand your potential exposure risk and when to seek medical care.
💬 Ask your doctorAndes hantavirus infection
GrantNIH REPORTERMay 11

New NIH Grant: Human astrovirus interactions with the intestinal epithelial barrier — $187K at Unknown Institution

Scientists are studying how a virus called human astrovirus damages the intestines and causes diarrhea. The research focuses on understanding how the virus breaks down the protective barrier that lines the stomach and intestines, which normally keeps harmful germs out while letting nutrients in. This $187,000 grant will help researchers figure out exactly how this virus causes intestinal damage.

WHY IT MATTERSUnderstanding how astrovirus damages the intestinal barrier could lead to new treatments for severe diarrhea and intestinal infections, particularly in young children, elderly people, and immunocompromised patients who are most vulnerable to this virus.
ℹ Good to knowhuman astrovirus infection
Clinical trialUNITERAREMay 8

New Recruiting Trial: A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

Researchers are testing a new vaccine called CMV-MVA Triplex Vaccine to help patients who are receiving a special type of bone marrow transplant called haploidentical stem cell transplant. Cytomegalovirus (CMV) is a common virus that can cause serious problems after this type of transplant. This vaccine is designed to strengthen the body's immune system against CMV and prevent the virus from spreading in the blood.

WHY IT MATTERSThis trial is now recruiting patients undergoing haploidentical hematopoietic stem cell transplant at City of Hope Medical Center — CMV reactivation is a major cause of complications and death after this procedure, making this preventive vaccine potentially life-changing for transplant recipients.
💬 Ask your doctorCytomegalovirus infectionHematologic malignancies requiring stem cell transplant

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases